PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hematology & CBC/PK Activity
Hematology & CBCErythrocyte Glycolytic ATP Production

Erythrocyte Pyruvate Kinase (PK Activity)

Terminal glycolytic enzyme that catalyzes the transphosphorylation of phosphoenolpyruvate (PEP) to ADP, producing pyruvate and ATP.

Standard Range8.0 - 16.0 U/g Hgb
Optimal Longevity9.5 - 15.0 U/g Hgb
Measurement UnitU/g Hgb
Organ SystemErythrocyte Glycolytic ATP Production
Routine Panels:Non-Spherocytic Hemolytic Anemia

Standard vs. Optimal Reference RangesU/g Hgb

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: U/g Hgb
U/g Hgb
Presets:
5 U/g HgbOptimal Zone Target22 U/g Hgb
Optimal Longevity Zone(12.3 U/g Hgb)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

8.0 - 16.0 U/g Hgb

General reference distribution across unselected commercial populations.

Optimal Longevity Target

9.5 - 15.0 U/g Hgb

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Mature erythrocytes lack mitochondria and depend entirely on glycolysis for ATP to power sodium-potassium ATPase membrane pumps.

Differential Diagnosis

Elevated Levels (PK Activity High)

  • •Normal erythrocyte glycolytic ATP generation

Low Levels (PK Activity Low)

  • •Pyruvate kinase deficiency (congenital non-spherocytic hemolytic anemia, splenomegaly, jaundice)

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Erythrocyte Pyruvate Kinase (PK Activity) plays an essential physiological role in erythrocyte glycolytic atp production. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Deficiency causes chronic non-spherocytic hemolytic anemia due to erythrocyte ATP depletion, cellular dehydration, and splenic sequestration.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for PK Activity
  • Targeted organ system imaging or functional dynamic testing related to erythrocyte glycolytic atp production
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Erythrocyte Pyruvate Kinase - The New England Journal of Medicine (2021). PMID: 34090124
  • [2]PK Activity Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Common Panels:Non-Spherocytic Hemolytic Anemia
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Erythrocyte Pyruvate Kinase (PK Activity) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hematology & CBC Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousG6PD Enzyme Activity (G6PD)Hematology & CBCNextHemoglobin A2 Percentage (HbA2)Hematology & CBC